06022nam 2200481 450 991055687810332120221109194143.09783030780104(electronic bk.)9783030780098(MiAaPQ)EBC6938744(Au-PeEL)EBL6938744(CKB)21420003500041(PPN)261523007(EXLCZ)992142000350004120221109d2022 uy 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierStem cell surgery trials in heart failure and diabetes a concise guide /Jeffrey N. WeissCham, Switzerland :Springer,[2022]©20221 online resource (164 pages)Includes index.Print version: Weiss, Jeffrey N. Stem Cell Surgery Trials in Heart Failure and Diabetes Cham : Springer International Publishing AG,c2022 9783030780098 Intro -- Preface -- Contents -- Part I: Heart Failure (United States) -- Chapter 1: Bone Marrow-Derived Mesenchymal Stem Cells in Improving Heart Function in Patients with Heart Failure Caused by Anthracyclines -- Chapter 2: Donor Bone Marrow-Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients with Cardiomyopathy Caused by Anthracyclines -- Chapter 3: The Transendocardial Autologous Cells (hMSC) or (hMSC) and (hCSC) in Ischemic Heart Failure Trial -- Chapter 4: Regression of Fibrosis and Reversal of Diastolic Dysfunction in HFPEF Patients Treated with Allogeneic CDCs -- Chapter 5: Efficacy and Safety of Allogeneic Mesenchymal Precursor Cells (Rexlemestrocel-L) for the Treatment of Heart Failure -- Part II: Heart Failure (Europe) -- Chapter 6: Allogeneic Stem Cell Therapy in Heart Failure -- Chapter 7: Stem Cell Therapy in Advanced Heart Failure -- Chapter 8: Stem Cell Therapy in Ischemic Non-treatable Cardiac Disease -- Chapter 9: Infusion Intracoronary of Mononuclear Autologous Adult Non Expanded Stem Cells of Bone Marrow on Functional Recovery in Patients with Idiopathic Dilated Cardiomyopathy and Heart Failure -- Chapter 10: Cell Therapy in HFpEF -- Chapter 11: Compare the Effects of Single Versus Repeated Intracoronary Application of Autologous Bone Marrow-Derived Mononuclear Cells on Mortality in Patients with Chronic Post-infarction Heart Failure -- Chapter 12: Impact of Intracoronary Injection of Autologous BMMC for LV Contractility and Remodeling in Patients with STEMI -- Chapter 13: Stem Cell Therapy in Non-ischemic, Non-treatable Dilated Cardiomyopathies II: A Pilot Study -- Part III: Heart Failure (Iran) -- Chapter 14: IMMNC-HF: IntraMyocardial Injection of Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients -- Chapter 15: ICMNC-HF: IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients.Part IV: Heart Failure (China) -- Chapter 16: Treating Heart Failure with hPSC-CMs -- Part V: Diabetes Mellitus: Type 1 Diabetes (United States) -- Chapter 17: Cellular Therapy for Type 1 Diabetes Using Mesenchymal Stem Cells -- Chapter 18: A Pilot Study of the Therapeutic Potential of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 19: Clinical Application of Stem Cell Educator Therapy in Type 1 Diabetes -- Chapter 20: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part VI: Diabetes Mellitus: Type 1 Diabetes (China) -- Chapter 21: Stem Cell Educator Therapy in Diabetes -- Chapter 22: Reversal of Type 1 Diabetes in Children by Stem Cell Educator Therapy -- Part VII: Diabetes Mellitus: Type 1 Diabetes (China/Spain) -- Chapter 23: Stem Cell Educator Therapy in Type 1 Diabetes -- Part VIII: Diabetes Mellitus: Type 1 Diabetes (South America) -- Chapter 24: Mesenchymal Stem Cells in Patients with Type 1 Diabetes Mellitus -- Part IX: Diabetes Mellitus: Type 1 Diabetes (Canada) -- Chapter 25: Stem Cell Mobilization (Plerixafor) and Immunologic Reset in Type 1 Diabetes (T1DM) -- Part X: Diabetes Mellitus: Type 1 Diabetes (Middle East) -- Chapter 26: Mesenchymal Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Patients (MSCTXT1DM) -- Chapter 27: Use of Stem Cells in Diabetes Mellitus Type 1 -- Part XI: Diabetes Mellitus: Type 1 Diabetes (Sweden) -- Chapter 28: Wharton's Jelly-Derived Mesenchymal Stromal Cell-Repeated Treatment of Adult Patients Diagnosed with Type I Diabetes -- Part XII: Diabetes Mellitus: Type 2 Diabetes (United States) -- Chapter 29: Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial Dysfunction in Diabetic Subjects (ACESO) -- Chapter 30: Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease -- Part XIII: Diabetes Mellitus: Type 2 Diabetes (China).Chapter 31: Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cell Transplantation in Patients with Type 2 Diabetes Mellitus -- Chapter 32: Stem Cell Educator Therapy in Diabetes -- Chapter 33: Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy -- Part XIV: Diabetes Mellitus: Type 2 Diabetes (Near East) -- Chapter 34: BM-MNC and UCMSC for Type 2 Diabetes Mellitus Patients -- Part XV: Diabetes Mellitus: Type 2 Diabetes (Vietnam) -- Chapter 35: BM-MNC and UC-MSC Infusion for Type 2 Diabetes Mellitus Patients (T2DM) -- Part XVI: Other Thoughts -- Chapter 36: Conclusion -- References -- Index.DiabetesTreatmentStem cellsTransplantationHeart failureTreatmentDiabetesTreatment.Stem cellsTransplantation.Heart failureTreatment.616.46206Weiss Jeffrey N.927848MiAaPQMiAaPQMiAaPQ9910556878103321Stem Cell Surgery Trials in Heart Failure and Diabetes2818202UNINA